The Extracorporeal Membrane Oxygenation Machine Market was valued at USD 634.07 Mn in 2024, and the total revenue of the Extracorporeal Membrane Oxygenation Machine Market is expected to grow at a CAGR of 5.5% from 2025 to 2032, reaching nearly USD 973.1 Mn by 2032.Extracorporeal Membrane Oxygenation Machine Market Overview
The Extracorporeal membrane oxygenation (ECMO) is a life-sustaining technology that provides cardiac and respiratory support to individuals with severe respiratory failure. The ECMO circuit is made up of cannulas, a pump, a blender, and an oxygenator, which oxygenates the blood and removes carbon dioxide via an extracorporeal gas exchange device known as a membrane oxygenator. Severe acute respiratory distress syndrome (ARDS), acute hypercapnic respiratory failure, bridge lung transplantation, primary graft malfunction post-lung transplantation, and pulmonary hypertension with right ventricular failure are also potential indications for ECMO usage.To know about the Research Methodology :- Request Free Sample Report The Extracorporeal Membrane Oxygenation Machine market experienced significant growth by rising prevalence of cardiopulmonary diseases and increased adoption during the COVID-19 pandemic, which highlighted its critical role in treating acute respiratory distress syndrome (ARDS). Demand increased as hospitals expanded ECMO capable ICUs, while supply was bolstered by innovations such as portable systems and heparin coated circuits. North America dominated the market and accounting for 45% of revenue to its advanced healthcare infrastructure and high cardiovascular disease rates, followed by Asia Pacific, where cost effective solutions from players like Terumo and MicroPort gained traction. The report covered the Extracorporeal Membrane Oxygenation Machine Market dynamics, structure by analysing the market segments and projecting the Extracorporeal Membrane Oxygenation Machine Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies and regional presence in the Market.
Extracorporeal Membrane Oxygenation Machine Market Dynamics
Rising Cardiopulmonary Disease Burden and Technological Advancements to Boost ECMO Market Growth The increased prevalence of cardiopulmonary illnesses and respiratory failures is the primary Extracorporeal Membrane Oxygenation Machine market. According to the Centres for Disease Control and Prevention (CDC), one person dies from cardiovascular disease every 37 seconds in the United States. The growing use of extracorporeal membrane oxygenation (ECMO) has accelerated technical progress in these systems. The progress involves the use of hollow pumps, oxygenators, and heparin-coated cannulas in a variety of surgical applications. The reasons driving ECMO machine market growth include an increase in the number of hospitals delivering ECMO services and an increase in the number of awareness initiatives. According to the Federal Agency for Healthcare Research and Quality, 6890 ECMO treatments were conducted in the United States in 2014. Following that, the use of extracorporeal membrane oxygenation (ECMO) equipment in hospitals has skyrocketed. According to the Extracorporeal Life Support Organization (ELSO), the number of hospitals providing ECMO treatments increased from 108 in 2008 to 280. Additionally, the growing use of ECMO devices is propelling technical improvement in these systems. The most recent advancements include oxygenators, hollow pumps, and heparin-coated cannulas utilised in a variety of surgical applications. Moreover, newly designed ECMO devices are smaller in size, enhancing mobility and applicability. Portable adaptors and tiny ECMO machine circuits, which aid in the evacuation of critically ill patients, have also been created. The growing elderly population, along with the rising incidence of coronary heart disease, is driving up the use of ECMO machines. Coronary heart disease is a primary cause of mortality worldwide and is closely linked to age. According to the United Nations, the number of individuals aged 80 and older is expected to increase from 143 million in 2019 to 426 million by 2050. Expensive ECMO products to restrain the Extracorporeal Membrane Oxygenation Machine Market ECMO is a costly treatment. Aside from the costs of the systems, other charges include the cost of hospitalisation and the cost of extra disposable accessories. Additionally, a complete team of medical specialists is necessary to care for the patient having an ECMO operation, which increases the expense of the therapy, although the cost varies depending on the duration of its usage. The normal hospital stays for a patient receiving ECMO assistance is typically 1-2 weeks; however, this period might be extended depending on the severity of the sickness. This raises the total cost of the treatment, which most patients cannot afford. Rising Survival Rates to Create Opportunities in the ECMO Machine Market ECMO patient survival rates vary based on the underlying disease and the patient's age. VV-ECMO is intended for patients with possibly reversible respiratory failure, such as severe acute respiratory distress syndrome (ADRS), primary graft malfunction after a lung transplant, and pulmonary trauma. Patients with respiratory failure who get VV-ECMO have a higher chance of survival. Because of their potential to support failing circulatory systems with oxygenation functions, ECMO devices are also employed in cardiac applications. The use of these technologies for heart failure improves cardiac patient survival rates. Improving survival rates with ECMO is expected to offer the ECMO machine market attractive growth potential.Extracorporeal Membrane Oxygenation Machine Market Segment Analysis
Based on Components, the oxygenators segment accounted for 40.2% of the Extracorporeal Membrane Oxygenation Machine market revenue in 2024 and is expected to increase at a profitable pace during the forecast period. The high cost and rapid exchange rate for a different system account for the oxygenators' significant market size. Mechanical failure, pump head thrombosis, and acute oxygenator thrombosis are the primary causes of the oxygenator exchange rate. Pumps have a significant market share owing to their high cost and consumption. The pumps of ECMO devices assist in pumping blood from a patient to artificial lungs, which then return the blood to the patient after oxygenation. The segment's rise is largely owing to the increased use of pumps in ECMO procedures and the availability of numerous types of pumps, such as roller, impeller, and centrifugal. These pumps are utilised in a variety of ECMO techniques depending on their requirements.Based on the Modality, the veno-arterial category is expected to grow at a strong CAGR during the forecast period. The segment's biggest size is partly because of its widespread use in treating cardiac arrest patients, aiding with algorithm life support measures to restore blood circulation. The venovenous category accounted for a considerable proportion in 2024 and is expected to increase at a profitable pace over the forecast period. The venovenous ECMO (VV ECMO) circuit's principal role is to facilitate the exchange of oxygen and carbon dioxide. As a result, it has a wide range of applications in circumstances when lung support is required. The growing prevalence of chronic obstructive pulmonary disease is one of the primary drivers of the ECMO machine market. According to the WHO, there were 255 million cases of COPD worldwide, with this figure expected to rise further throughout the forecast period. Based on the Patient, Adult patients accounted for 62.0% of the Extracorporeal Membrane Oxygenation Machine market revenue in 2024 and are expected to expand at the quickest rate throughout the forecast period. Alcohol, tobacco, and smoking use, combined with a sedentary lifestyle, are contributing to an increase in the global burden of heart and respiratory disorders in adults. According to data provided by the Extracorporeal Life Support Organization, there were around 7,950 persons suffering from cardiac diseases who required ECMO. The pediatric category also had a sizable market share and is predicted to grow at a rapid rate during the forecast period. The growing number of youngsters suffering from various pulmonary cardiac ailments is one of the segment's primary drivers.
Extracorporeal Membrane Oxygenation Machine Market Regional Insights
North America led the worldwide market and accounted for the biggest revenue share of 45% in 2024, owing to the rising incidence of cardiovascular and respiratory disorders, technical developments in ECMO technology, and increased use of ECMO systems. According to the Centers for Disease Control and Prevention (CDC), 659,000 individuals in the United States would die from heart disease, accounting for one out of every four fatalities. In addition, about 805,000 people in the United States experience heart attacks. The region's requirement for Extracorporeal Membrane Oxygenation (ECMO) is also growing owing to the increased adoption of new technological goods and changes in lifestyle choices that result in chronic diseases such as cardiac and respiratory ailments. An increase in the number of improvements and sophisticated technology in these Extracorporeal Membrane Oxygenation (ECMO) devices, as well as an increase in public awareness of their many applications, has resulted in a significant quantity of output for hospitals. Additionally, in the United States, high blood pressure, obesity, type 2 diabetes, and poor eating habits have all increased the number of instances of cardiovascular disease. ECMO (extracorporeal membrane oxygenation) has the potential to reduce the number of in-hospital mortalities. Moreover, statistics published by the American Thoracic Society (ATS) suggest that the United States spends around USD 80.5 billion on asthma-related expenses each year. Given the high mortality rates from cardiovascular illnesses and the growing spending on asthma treatment, the business under examination has plenty of space for growth. Furthermore, the market for Extracorporeal Membrane Oxygenation (ECMO) is growing as a result of rising government healthcare spending to improve healthcare services.Extracorporeal Membrane Oxygenation Machine Market Competitive Landscape
Extracorporeal Membrane Oxygenation Machine Market is dominated by major key players like Medtronic plc, LivaNova PLC, Getinge AB, Terumo Corporation and MicroPort Scientific Corporation. Companies are led by their strong R&D investments, strategic acquisitions and innovative product launches. Medtronic stands out with its advanced ECMO systems and focus on minimally invasive technologies, and LivaNova excels in cardiopulmonary solutions with its Sorin Group legacy in oxygenators and perfusion systems. Getinge AB leverages its Maquet Holdings expertise in critical care, offering high-performance ECMO machines with enhanced safety features. Terumo Corporation leads in Asia Pacific with its cutting-edge membrane oxygenators and portable ECMO devices. MicroPort Scientific is gaining traction with its cost effective solutions and expanding its global footprint. These companies maintain dominance by its strategic collaborations, regulatory approvals and technological advancements, like miniaturised ECMO systems, improved biocompatibility and AI-driven monitoring. Strong distribution networks and a focus on emerging markets further solidify their positions. Also, regional players like Braile Biomédica and Jafron Biomedical are growing by catering to local demand with affordable alternatives, though they lack global reach of industry leaders.Extracorporeal Membrane Oxygenation Machine Market Key Trends
Extracorporeal Membrane Oxygenation Machine Market Recent Development • Getinge AB (United States) June 30, 2025: Launched a neonatal version of its Servo-c ventilator capable of supporting premature infants weighing as little as 500 g. • Novalung GmbH (Germany) November 19, 2024: Fresenius Medical Care’s heart and lung division, which includes Novalung, secured a national group purchasing agreement with Premier, Inc. in the U.S. This enables over 4,350 Premier member hospitals to access the FDA-cleared Novalung ECMO system under pre-negotiated terms, enhancing its market reach and affordability. • Estor S.p.A (Italy) October 23, 2023: Partnered with Nikkiso Europe to distribute the ProLUNG extracorporeal CO₂ removal system across multiple countries (UK, Ireland, Germany, Spain, Thailand, Colombia), operational from January 1, 2024. This expands its footprint in minimally invasive respiratory support markets.
Trend Description Impact on Market Technological Advancements Development of portable, miniaturised ECMO systems with improved oxygenators and heparin-coated circuits. Enhances patient mobility, reduces complications, and expands use in emergency & neonatal care. Rising Demand Due to COVID-19 & Pandemics Increased ECMO adoption for severe respiratory failure patients during outbreaks. Surge in demand post-pandemic, with hospitals investing in ECMO-capable ICUs. Growing Preference for Ambulatory ECMO Shift toward mobile ECMO units for inter-hospital transfers and remote care. Expands market reach, especially in emerging economies with limited ICU infrastructure. Extracorporeal Membrane Oxygenation Machine Market Scope: Inquire before buying
Global Extracorporeal Membrane Oxygenation Machine Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 634.07 Mn. Forecast Period 2025 to 2032 CAGR: 5.5% Market Size in 2032: USD 973.1 Mn. Segments Covered: by Component Pumps Oxygenator Controllers Cannula Accessories by Modality Veno-Arterial Veno-Venous Arterio-Venous by Patient Neonates Pediatric Adult by Application Respiratory Cardiac ECPR Extracorporeal Membrane Oxygenation Machine Market, by Region
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, Indonesia, Philippines, Malaysia, Vietnam, Thailand, ASEAN, Rest of Asia Pacific) Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A) South America (Brazil, Argentina, Rest of South America)Extracorporeal Membrane Oxygenation Machine Market, Key Players
North America 1. Medtronic plc (United States) 2. ABIOMED Inc. (United States) 3. LivaNova PLC (United States) 4. Getinge AB (United States) 5. MicroPort Scientific Corporation (United States) 6. CytoSorbents Corporation (United States) 7. Pfizer Inc. (United States) 8. Nipro Corporation (United States) Europe 9. Sorin Group (Italy) 10. Eurosets S.r.l. (Italy) 11. Xenios AG (Germany) 12. MAQUET Holding B.V. & Co. KG (Germany) 13. Novalung GmbH (Germany) 14. Medos Medizintechnik AG (Germany) 15. Estor SpA (Italy) Asia Pacific 16. Terumo Corporation (Japan) 17. Senko Medical Instrument Mfg. Co., Ltd. (Japan) 18. Fuji Systems Corporation (Japan) 19. Sarns (Japan) 20. Nihon Kohden Corporation (Japan) 21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) 22. Jafron Biomedical Co., Ltd. (China) Middle East and Africa 23. Egyptian Italian Co. for Medical Equipment (Egypt) South America 24. Braile Biomédica (Brazil) 25. Embramed Indústria e Comércio de Equipamentos Hospitalares (Brazil) 26. Fanem Ltda. (Brazil) FAQ: 1] What Major Key players in the Extracorporeal Membrane Oxygenation Machine Market report? Ans. The top companies in the Extracorporeal Membrane Oxygenation (ECMO) Machine Market include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG, ABIOMED Inc., MicroPort Scientific Corporation, and MAQUET Holding B.V. & Co. KG. 2] Which region has the largest share in the Extracorporeal Membrane Oxygenation Machine Market? Ans. The North America region held the highest share in 2024. 3] What is the market size of the Extracorporeal Membrane Oxygenation Machine Market by 2032? Ans. The market size of the Extracorporeal Membrane Oxygenation Machine Market by 2032 is expected to reach USD 973.1 Million. 4] What is the forecast period for the Extracorporeal Membrane Oxygenation Machine Market? Ans. Global Extracorporeal Membrane Oxygenation Machine Market (AMS) report helps with the PESTEL, Porter's, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 5] What was the market size of the Extracorporeal Membrane Oxygenation Machine Market in 2024? Ans. The market size of the Extracorporeal Membrane Oxygenation Machine Market in 2024 was valued at USD 634.07 Million.
1. Extracorporeal Membrane Oxygenation Machine Market Introduction 1.1. Study Assumptions and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Extracorporeal Membrane Oxygenation Machine Market: Competitive Landscape 2.1. Ecosystem Analysis 2.2. MMR Competition Matrix 2.3. Competitive Landscape 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. Service Segment 2.4.4. End-User Segment 2.4.5. Revenue (2024) 2.4.6. Geographical Presence 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 2.7. KANO Model Analysis 3. Global Extracorporeal Membrane Oxygenation Machine Market: Dynamics 3.1. Region-wise Trends of Extracorporeal Membrane Oxygenation Machine Market 3.1.1. North America Extracorporeal Membrane Oxygenation Machine Market Trends 3.1.2. Europe Extracorporeal Membrane Oxygenation Machine Market Trends 3.1.3. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Trends 3.1.4. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Trends 3.1.5. South America Extracorporeal Membrane Oxygenation Machine Market Trends 3.2. Extracorporeal Membrane Oxygenation Machine Market Dynamics 3.2.1. Extracorporeal Membrane Oxygenation Machine Market Drivers 3.2.1.1. Rising Cardiopulmonary Disease 3.2.1.2. Technological Advancements in ECMO 3.2.2. Extracorporeal Membrane Oxygenation Machine Market Restraints 3.2.3. Extracorporeal Membrane Oxygenation Machine Market Opportunities 3.2.3.1. Higher Survival Rates 3.2.3.2. Portable ECMO Devices 3.2.3.3. Expanding Hospital Adoption 3.2.4. Extracorporeal Membrane Oxygenation Machine Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.4.1. Innovations in oxygenators and pumps 3.4.2. Healthcare policy support for critical care 3.4.3. Awareness campaigns on ECMO availability 3.5. Regulatory Landscape by Region 3.6. Key Opinion Leader Analysis for the Global Industry 3.7. Analysis of Government Schemes and Initiatives for Industry 4. Extracorporeal Membrane Oxygenation Machine Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 4.1. Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 4.1.1. Pumps 4.1.2. Oxygenator 4.1.3. Controllers 4.1.4. Cannula 4.1.5. Accessories 4.2. Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 4.2.1. Veno-Arterial 4.2.2. Veno-Venous 4.2.3. Arterio-Venous 4.3. Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 4.3.1. Neonates 4.3.2. Pediatric 4.3.3. Adult 4.4. Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 4.4.1. Respiratory 4.4.2. Cardiac 4.4.3. ECPR 4.5. Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Region (2024-2032) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 5.1. North America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 5.1.1. Pumps 5.1.2. Oxygenator 5.1.3. Controllers 5.1.4. Cannula 5.1.5. Accessories 5.2. North America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 5.2.1. Veno-Arterial 5.2.2. Veno-Venous 5.2.3. Arterio-Venous 5.3. North America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 5.3.1. Neonates 5.3.2. Pediatric 5.3.3. Adult 5.4. North America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 5.4.1. Respiratory 5.4.2. Cardiac 5.4.3. ECPR 5.5. North America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, by Country (2024-2032) 5.5.1. United States 5.5.1.1. United States Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 5.5.1.1.1. Pumps 5.5.1.1.2. Oxygenator 5.5.1.1.3. Controllers 5.5.1.1.4. Cannula 5.5.1.1.5. Accessories 5.5.1.2. United States Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 5.5.1.2.1. Veno-Arterial 5.5.1.2.2. Veno-Venous 5.5.1.2.3. Arterio-Venous 5.5.1.3. United States Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 5.5.1.3.1. Neonates 5.5.1.3.2. Pediatric 5.5.1.3.3. Adult 5.5.1.4. United States Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 5.5.1.4.1. Respiratory 5.5.1.4.2. Cardiac 5.5.1.4.3. ECPR 5.5.2. Canada 5.5.2.1. Canada Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 5.5.2.1.1. Pumps 5.5.2.1.2. Oxygenator 5.5.2.1.3. Controllers 5.5.2.1.4. Cannula 5.5.2.1.5. Accessories 5.5.2.2. Canada Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 5.5.2.2.1. Veno-Arterial 5.5.2.2.2. Veno-Venous 5.5.2.2.3. Arterio-Venous 5.5.2.3. Canada Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 5.5.2.3.1. Neonates 5.5.2.3.2. Pediatric 5.5.2.3.3. Adult 5.5.2.4. Canada Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 5.5.2.4.1. Respiratory 5.5.2.4.2. Cardiac 5.5.2.4.3. ECPR 5.5.3. Mexico 5.5.3.1. Mexico Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 5.5.3.1.1. Pumps 5.5.3.1.2. Oxygenator 5.5.3.1.3. Controllers 5.5.3.1.4. Cannula 5.5.3.1.5. Accessories 5.5.3.2. Mexico Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 5.5.3.2.1. Veno-Arterial 5.5.3.2.2. Veno-Venous 5.5.3.2.3. Arterio-Venous 5.5.3.3. Mexico Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 5.5.3.3.1. Neonates 5.5.3.3.2. Pediatric 5.5.3.3.3. Adult 5.5.3.4. Mexico Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 5.5.3.4.1. Respiratory 5.5.3.4.2. Cardiac 5.5.3.4.3. ECPR 6. Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 6.1. Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.2. Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.3. Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.4. Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5. Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, by Country (2024-2032) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.1.2. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.1.3. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.1.4. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.2. France 6.5.2.1. France Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.2.2. France Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.2.3. France Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.2.4. France Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.3. Germany 6.5.3.1. Germany Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.3.2. Germany Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.3.3. Germany Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.3.4. Germany Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.4. Italy 6.5.4.1. Italy Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.4.2. Italy Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.4.3. Italy Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.4.4. Italy Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.5. Spain 6.5.5.1. Spain Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.5.2. Spain Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.5.3. Spain Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.5.4. Spain Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.6. Sweden 6.5.6.1. Sweden Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.6.2. Sweden Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.6.3. Sweden Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.6.4. Sweden Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.7. Russia 6.5.7.1. Russia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.7.2. Russia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.7.3. Russia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.7.4. Russia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 6.5.8.2. Rest of Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 6.5.8.3. Rest of Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 6.5.8.4. Rest of Europe Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 7.1. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.2. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.3. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.4. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, by Country (2024-2032) 7.5.1. China 7.5.1.1. China Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.1.2. China Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.1.3. China Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.1.4. China Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.2. S Korea 7.5.2.1. S Korea Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.2.2. S Korea Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.2.3. S Korea Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.2.4. S Korea Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.3. Japan 7.5.3.1. Japan Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.3.2. Japan Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.3.3. Japan Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.3.4. Japan Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.4. India 7.5.4.1. India Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.4.2. India Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.4.3. India Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.4.4. India Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.5. Australia 7.5.5.1. Australia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.5.2. Australia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.5.3. Australia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.5.4. Australia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.6. Indonesia 7.5.6.1. Indonesia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.6.2. Indonesia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.6.3. Indonesia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.6.4. Indonesia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.7. Malaysia 7.5.7.1. Malaysia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.7.2. Malaysia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.7.3. Malaysia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.7.4. Malaysia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.8. Philippines 7.5.8.1. Philippines Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.8.2. Philippines Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.8.3. Philippines Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.8.4. Philippines Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.9. Thailand 7.5.9.1. Thailand Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.9.2. Thailand Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.9.3. Thailand Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.9.4. Thailand Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.10. Vietnam 7.5.10.1. Vietnam Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.10.2. Vietnam Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.10.3. Vietnam Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.10.4. Vietnam Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 7.5.11. Rest of Asia Pacific 7.5.11.1. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 7.5.11.2. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 7.5.11.3. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 7.5.11.4. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 8. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast (by Value in USD Million) (2024-2032 8.1. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 8.2. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 8.3. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 8.4. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 8.5. Middle East and Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, by Country (2024-2032) 8.5.1. South Africa 8.5.1.1. South Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 8.5.1.2. South Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 8.5.1.3. South Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 8.5.1.4. South Africa Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 8.5.2. GCC 8.5.2.1. GCC Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 8.5.2.2. GCC Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 8.5.2.3. GCC Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 8.5.2.4. GCC Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 8.5.3. Egypt 8.5.3.1. Egypt Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 8.5.3.2. Egypt Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 8.5.3.3. Egypt Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 8.5.3.4. Egypt Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 8.5.4. Nigeria 8.5.4.1. Nigeria Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 8.5.4.2. Nigeria Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 8.5.4.3. Nigeria Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 8.5.4.4. Nigeria Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 8.5.5. Rest of ME&A 8.5.5.1. Rest of ME&A Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 8.5.5.2. Rest of ME&A Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 8.5.5.3. Rest of ME&A Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 8.5.5.4. Rest of ME&A Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 9. South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032 9.1. South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 9.2. South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 9.3. South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 9.4. South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 9.5. South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, by Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 9.5.1.2. Brazil Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 9.5.1.3. Brazil Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 9.5.1.4. Brazil Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 9.5.2.2. Argentina Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 9.5.2.3. Argentina Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 9.5.2.4. Argentina Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 9.5.3. Colombia 9.5.3.1. Colombia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 9.5.3.2. Colombia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 9.5.3.3. Colombia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 9.5.3.4. Colombia Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 9.5.4. Chile 9.5.4.1. Chile Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 9.5.4.2. Chile Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 9.5.4.3. Chile Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 9.5.4.4. Chile Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 9.5.5. Rest Of South America 9.5.5.1. Rest Of South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Component (2024-2032) 9.5.5.2. Rest Of South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Modality (2024-2032) 9.5.5.3. Rest Of South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Patient (2024-2032) 9.5.5.4. Rest Of South America Extracorporeal Membrane Oxygenation Machine Market Size and Forecast, By Application (2024-2032) 10. Company Profile: Key Players 10.1. Medtronic plc (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. ABIOMED Inc. (United States) 10.3. LivaNova PLC (United States) 10.4. Getinge AB (United States) 10.5. MicroPort Scientific Corporation (United States) 10.6. CytoSorbents Corporation (United States) 10.7. Pfizer Inc. (United States) 10.8. Nipro Corporation (United States) 10.9. Sorin Group (Italy) 10.10. Eurosets S.r.l. (Italy) 10.11. Xenios AG (Germany) 10.12. MAQUET Holding B.V. & Co. KG (Germany) 10.13. Novalung GmbH (Germany) 10.14. Medos Medizintechnik AG (Germany) 10.15. Estor SpA (Italy) 10.16. Terumo Corporation (Japan) 10.17. Senko Medical Instrument Mfg. Co., Ltd. (Japan) 10.18. Fuji Systems Corporation (Japan) 10.19. Sarns (Japan) 10.20. Nihon Kohden Corporation (Japan) 10.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) 10.22. Jafron Biomedical Co., Ltd. (China) 10.23. Egyptian Italian Co. for Medical Equipment (Egypt) 10.24. Braile Biomédica (Brazil) 10.25. Embramed Indústria e Comércio de Equipamentos Hospitalares (Brazil) 10.26. Fanem Ltda. (Brazil) 11. Key Findings 12. Industry Recommendations 13. Extracorporeal Membrane Oxygenation Machine Market: Research Methodology
